Efficacy and Safety of an LVEF-Guided Mavacamten Dose Up-Titration Strategy in Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Sep 9, 2026 - P4 | N=115 | Not yet recruiting | Sponsor: Second Affiliated Hospital of Nanchang University
New P4 trial • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|